| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/08/2023 | -33.82% | Jefferies | $0.8 → $0.4 | Downgrades | Hold → Underperform |
| 01/05/2023 | -17.27% | B of A Securities | $5 → $0.5 | Downgrades | Buy → Underperform |
| 12/27/2022 | 230.91% | SVB Leerink | $15 → $2 | Downgrades | Outperform → Market Perform |
| 12/23/2022 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
| 12/02/2022 | 396.36% | Chardan Capital | → $3 | Initiates Coverage On | → Buy |
| 11/08/2022 | 2381.8% | SVB Leerink | $21 → $15 | Maintains | Outperform |
| 07/07/2022 | — | Jefferies | Downgrades | Buy → Hold | |
| 05/20/2022 | 3374.52% | SVB Leerink | $60 → $21 | Maintains | Outperform |
| 05/19/2022 | 8172.67% | JMP Securities | $86 → $50 | Maintains | Market Outperform |
| 05/10/2022 | 9827.2% | SVB Leerink | $74 → $60 | Maintains | Outperform |
| 03/17/2021 | 15121.71% | JMP Securities | → $92 | Initiates Coverage On | → Outperform |
| 02/22/2021 | 12143.55% | SVB Leerink | $32 → $74 | Maintains | Outperform |
| 06/30/2020 | 6187.23% | Jefferies | → $38 | Initiates Coverage On | → Buy |
| 06/30/2020 | 5525.41% | B of A Securities | → $34 | Initiates Coverage On | → Buy |
| 06/30/2020 | 5194.51% | SVB Leerink | → $32 | Initiates Coverage On | → Outperform |
What is the target price for Applied Molecular (AMTI)?
The latest price target for Applied Molecular (NASDAQ: AMTI) was reported by Jefferies on February 8, 2023. The analyst firm set a price target for $0.40 expecting AMTI to fall to within 12 months (a possible -33.82% downside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Applied Molecular (AMTI)?
The latest analyst rating for Applied Molecular (NASDAQ: AMTI) was provided by Jefferies, and Applied Molecular downgraded their underperform rating.
When is the next analyst rating going to be posted or updated for Applied Molecular (AMTI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Applied Molecular, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Applied Molecular was filed on February 8, 2023 so you should expect the next rating to be made available sometime around February 8, 2024.
Is the Analyst Rating Applied Molecular (AMTI) correct?
While ratings are subjective and will change, the latest Applied Molecular (AMTI) rating was a downgraded with a price target of $0.80 to $0.40. The current price Applied Molecular (AMTI) is trading at is $0.60, which is out of the analyst's predicted range.